Search Results - "Dunn, Fredrick L"

Refine Results
  1. 1

    Effect of Colesevelam Hydrochloride on Glycemia and Insulin Sensitivity in Men With the Metabolic Syndrome by Vega, Gloria Lena, PhD, Dunn, Fredrick L., MD, Grundy, Scott M., MD, PhD

    Published in The American journal of cardiology (15-10-2011)
    “…Colesevelam hydrochloride (colesevelam) lowers low-density lipoprotein (LDL) cholesterol and glycated hemoglobin in patients with type 2 diabetes mellitus. The…”
    Get full text
    Journal Article
  2. 2

    Can a selective PPARγ modulator improve glycemic control in patients with type 2 diabetes with fewer side effects compared with pioglitazone? by DePaoli, Alex M, Higgins, Linda S, Henry, Robert R, Mantzoros, Christos, Dunn, Fredrick L

    Published in Diabetes care (01-07-2014)
    “…INT131 besylate is a potent, nonthiazolidinedione, selective peroxisome proliferator-activated receptor γ (PPARγ) modulator (SPPARM) designed to improve…”
    Get full text
    Journal Article
  3. 3

    Selective modulation of PPARγ activity can lower plasma glucose without typical thiazolidinedione side-effects in patients with Type 2 diabetes by Dunn, Fredrick L, Higgins, Linda S, Fredrickson, Jill, DePaoli, Alex M

    Published in Journal of diabetes and its complications (01-05-2011)
    “…Abstract Objective INT131 besylate is a potent non-thiazolidinedione selective peroxisome proliferator-activated receptor γ (PPARγ)  modulator (SPPARM)…”
    Get full text
    Journal Article
  4. 4

    Management of dyslipidemia in people with type 2 diabetes mellitus by Dunn, Fredrick L

    Published in Reviews in endocrine & metabolic disorders (01-03-2010)
    “…Cardiovascular disease is a major complication of type 2 diabetes mellitus, and this is partly due to associated abnormalities of plasma lipid and lipoprotein…”
    Get full text
    Journal Article
  5. 5

    U500 regular insulin use in insulin-resistant type 2 diabetic veteran patients by Ziesmer, Anne E, Kelly, Kevin C, Guerra, Patricia A, George, Karen G, Dunn, Fredrick L

    Published in Endocrine practice (01-01-2012)
    “…To evaluate the use of U500 regular insulin therapy in insulin-resistant patients with type 2 diabetes mellitus who were previously treated with high-dosage…”
    Get more information
    Journal Article
  6. 6

    Impaired Hepatic Ketogenesis in Moderately Obese Men With Hypertriglyceridemia by Vega, Gloria Lena, Dunn, Fredrick L., Grundy, Scott M.

    Published in Journal of investigative medicine (01-04-2009)
    “…BackgroundSeveral studies suggest that increased nonesterified fatty acid flux and increased de novo lipogenesis may contribute to hypertriglyceridemia, but…”
    Get full text
    Journal Article
  7. 7

    Screening for microalbuminuria. A comparison of single sample methods of collection and techniques of albumin analysis by Schwab, S J, Dunn, F L, Feinglos, M N

    Published in Diabetes care (01-11-1992)
    “…Screening for microalbuminuria. A comparison of single sample methods of collection and techniques of albumin analysis. S J Schwab , F L Dunn and M N Feinglos…”
    Get full text
    Journal Article
  8. 8

    Plasma lipid and lipoprotein disorders in IDDM by DUNN, F. L

    Published in Diabetes (New York, N.Y.) (01-10-1992)
    “…Abnormal lipoprotein metabolism contributes to the increased risk of premature atherosclerosis in people with insulin-dependent (type I) diabetes. Although…”
    Get full text
    Conference Proceeding Journal Article
  9. 9

    Long-term therapy of IDDM with an implantable insulin pump by DUNN, F. L, NATHAN, D. M, SCAVINI, M, SELAM, J.-L, WINGROVE, T. G

    Published in Diabetes care (1997)
    “…OBJECTIVE To examine the long-term benefits and risks of treatment of IDDM with an implantable programmable insulin pump. RESEARCH DESIGN AND METHODS…”
    Get full text
    Journal Article
  10. 10

    Can a Selective PPAR? Modulator Improve Glycemic Control in Patients With Type 2 Diabetes With Fewer Side Effects Compared With Pioglitazone? by DePaoli, Alex M, Higgins, Linda S, Henry, Robert R, Mantzoros, Christos, Dunn, Fredrick L

    Published in Diabetes care (01-07-2014)
    “…INT131 besylate is a potent, nonthiazolidinedione, selective peroxisome proliferator-activated receptor γ (PPARγ) modulator (SPPARM) designed to improve…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Catheter Survival During Long-Term Insulin Therapy With an Implanted Programmable Pump by Scavini, Marina, Galli, Laura, Reich, Sanford, Eaton, R Philip, Charles, M Arthur, Dunn, Fredrick L

    Published in Diabetes care (01-04-1997)
    “…OBJECTIVE To survey catheter complications and to analyze catheter survival during long-term intraperitoneal and intravenous insulin therapy with an implanted…”
    Get full text
    Journal Article
  13. 13

    The role of blood osmolality and volume in regulating vasopressin secretion in the rat by Dunn, F L, Brennan, T J, Nelson, A E, Robertson, G L

    Published in The Journal of clinical investigation (01-12-1973)
    “…A sensitive and specific radioimmunoassay for plasma arginine vasopressin (AVP) has been used to study the effects of blood osmolality and volume in regulating…”
    Get full text
    Journal Article
  14. 14

    Selective modulation of PPAR[gamma] activity can lower plasma glucose without typical thiazolidinedione side-effects in patients with Type 2 diabetes by Dunn, Fredrick L, Higgins, Linda S, Fredrickson, Jill, DePaoli, Alex M

    Published in Journal of diabetes and its complications (01-05-2011)
    “…INT131 besylate is a potent non-thiazolidinedione selective peroxisome proliferator-activated receptor γ (PPARγ) modulator (SPPARM) designed to improve insulin…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    Management of hyperlipidemia in diabetes mellitus by Dunn, F L

    “…Accelerated atherosclerosis is a major complication of long-term diabetes mellitus, and this is partly due to associated abnormalities of lipoprotein…”
    Get more information
    Journal Article
  18. 18

    Effects of insulin treatment on lipoprotein composition and function in patients with IDDM by BAGDADE, J. D, DUNN, F. L

    Published in Diabetes (New York, N.Y.) (01-10-1992)
    “…Normolipidemic patients of both sexes with insulin-dependent diabetes mellitus have the same pervasive changes in lipoprotein surface and core lipid…”
    Get full text
    Conference Proceeding Journal Article
  19. 19

    Treatment of lipid disorders in diabetes mellitus by Dunn, F L

    Published in The Medical clinics of North America (01-11-1988)
    “…One reason for premature atherosclerosis in patients with diabetes mellitus is abnormal lipid metabolism. This article discusses the plasma lipid disorders…”
    Get more information
    Journal Article
  20. 20

    The effect of continuous subcutaneous insulin infusion on very-low-density lipoprotein triglyceride metabolism in type I diabetes mellitus by Pietri, A O, Dunn, F L, Grundy, S M, Raskin, P

    Published in Diabetes (New York, N.Y.) (01-01-1983)
    “…The effect of continuous subcutaneous insulin infusion (CSII) on very-low-density lipoprotein triglyceride (VLDL-TG) metabolism was studied in seven…”
    Get full text
    Journal Article